3 day course - Cancer: Nutritional support before, during and after treatment and beyond


Watch the trailer 


Overview  

This CPD course...

  • is delivered: As an online on-demand-video from a live course 
  • is for: Nutritional therapists, nutritionists, dieticians, naturopaths, other health care providers, and final year nutrition students interested in applying  functional medicine approaches to health and well-being (i.e. exploring how nutrients, other foods and lifestyle factors influence the function of the body and how to apply findings in a person–centred manner that recognises individuals’ unique differences)
  • is with: Dr Carol Granger
  • spans: 15 hours recording time
  • provides: BANT CPD 15 hours; NNA 15 hours; NTOI 15 hours

Safe, practical and evidence-informed nutritional support for people affected by cancer may enhance the effectiveness of medical treatments and reduce side effects; reduce the risk of cancer recurrence and improve overall wellbeing. 

Personalised medicine approaches are playing an increasingly important role in cancer prevention, diagnosis, prognosis and therapeutics.  Health practitioners now working in this field need to understand both ‘mainstay treatment options i.e. chemotherapy, radiotherapy and surgery as well as newer biological and immunotherapy drug regimens when developing their recommendations. Practitioners also need to understand related terminology and how to effectively communicate and collaborate with medical teams within this new paradigm.   

ION’s updated three day course aims to help practitioners gain confidence across a range of cancers by setting a foundation for further understanding and exploration. Specific cases will be used to illustrate common treatment regimens for colorectal, breast, ovarian and lung cancer cases and melanoma cases and appropriate nutritional support alongside these.   

ION's courses have a strong reputation for providing impartial and evidence-informed education. This course has been structured and designed based on best practice in delivering an effective and interactive online learning experience.

Part/Day 1 - Cancer pathophysiology, medical definitions and  conventional and newer treatment modalities

This day sets the scene for developing participants’ deeper understanding of cancer as a group of conditions. The day consolidates participants’ understanding regarding changes at a genetic, cellular and systems-based levels affecting a client with a diagnosis of cancer. The processes of diagnosis and treatment managed within the NHS are outlined, reviewing cancer pathophysiology, biological mechanisms, diagnostic criteria and ‘mainstay’ treatments of chemotherapy, radiotherapy and surgery. Newer drugs that target specific pathways or growth factors, or modulate the immune response will be introduced. The principles of integrative and collaborative care are considered.

Part/Day 2 - Integrative  nutrition support  through the cancer journey alongside mainstay treatments

This day provides a top-line review of the role of modifiable factors in the occurrence of common cancers.  Nutritional support for clients receiving ‘mainstay’ treatments are considered. Particular focus will be given to   gastrointestinal and hepato-biliary tract cancers and hormone-dependent cancers. The day considers how to support treatment efficacy, help reduce side effects and considers modifiable cancer- specific risk factors for cancer recurrence.  Participants will be taken through the rationale for appropriate approaches.

Part/Day 3 - Integrative nutrition support through the cancer journey alongside novel therapies.

This day looks at the impact of targeted and biological therapies on metabolic and nutritional status and how best to use nutrition and supplement approaches to support individuals receiving these treatments, Case studies examining the use of tyrosine kinase inhibitors for lung cancer, PARP inhibitors alongside chemotherapy for ovarian cancer, and checkpoint inhibitors for advanced melanoma will be used. The day concludes with briefing for the course assessment, which consolidates approaches for developing effective collaborations and ensuring patient safety.

Please see the What will be covered? section below for a full timetable for each day

Book

 


What will I learn?

By the end of the recording you will be able to:

  • A deeper and more systematic understanding of cancer pathogenesis and development; the roles of inherited and modifiable factors; how diagnosis and treatment decisions are routinely made and a greater familiarity with routine oncology terminology. 
  • An increased critical appreciation of current research in relation to dietary and lifestyle risk and protective factors for different cancers; mechanisms of action and implications for nutritional recommendations throughout the cancer journey. 
  • An understanding of the use of mainstay cancer treatments of chemotherapy, surgery and radiotherapy, and the newer targeted and biological treatments  
  • A greater ability to apply evidence in the development of dietary recommendations, tests, and supplements for clients receiving different types of cancer treatments 
  • A greater awareness and ability to consider elements of the therapeutic relationship including safety, legal, ethical issues, professional boundary setting; when to refer to other practitioners or medical professionals and how to develop effective medical collaborations. 
  • A greater ability to analyse clinical cases more effectively and to communicate with oncology specialists.  

What will be covered?

Cancer pathophysiology, medical definitions and  conventional and newer treatment modalities

Session 1  

  • Overview of cancer as a group of diseases:  What do current incidence and prevalence data tell us?
  • Cancer pathophysiology: Understanding genetic factors, inherited and acquired mutations, epigenetic modifications, changes in cell behaviour and tissues changes
  • Consolidation of learning with individual exercise
  • Understanding stem cell theory, tumour metabolic reprogramming, and tumour stages to metastasis.
  • Q and A

Session 2

  • The response of the immune system in malignancy
  • Modifiable factors in the cancer process – nutrition, exercise, environmental exposures
  • Consolidation of learning with individual exercise
  • Q and A

Session 3

  • Understanding the Patient’s Journey.  Diagnosis, staging and grading. Testing for markers and treatment choices.
  • Overview of traditional treatment modalities – chemotherapy, surgery and radiotherapy
  • Q and A

Session 4

  • Principle of targeted drug treatments: targets within hormonal  pathways and growth factor targets
  • Principles of immunotherapies: Key immune system targets
  • Medical perspectives on complementary and ‘alternative’ treatments during cancer treatment and appropriate framing of integrative cancer care. The benefits of a whole person approach for people affected by cancer.
  • Q and A

Integrative  nutrition support through the cancer journey alongside mainstay treatments

Session 1

  • The contribution of diet to cancer prevention and risk: Findings and implications of EPIC and other studies.
  • Understanding gastrointestinal and hepato -biliary tract cancers. Case study of patient with colorectal cancer being treated with chemotherapy and surgery.  
  • Contribution of specific dietary components as cancer risk factors and protective factors
  • Case study exercise: Understanding food- derived carcinogens and protective agents.  
  • Q and A

Session 2

  • Supporting the patient through the treatment journey: Chemotherapy  and surgical aims and approaches
  • Dietary factors influencing bowel recovery: Applying the evidence on appropriate dietary approaches
  • Safe supplementation before, during and after treatment with chemotherapy and surgery
  • Case study exercise: Developing long term support for a colorectal cancer survivor
  • Q and A

Session 3

  • Hormone dependent cancers: Case study of a patient with oestrogen- driven breast cancer with surgery, chemotherapy, radiotherapy and hormone therapy
  • Impact of obesity, adiposity and dysglycaemia on cancer pathogenesis
  • Contribution of specific dietary components as risk factors and protective factors and their interrelationship with insulin, IGF-1, oestrogen, progesterone and testosterone.
  • Critical review of trials targeting energy metabolism in breast cancer patients: Implications for supporting clients before, during and after treatment and beyond.
  • Evidence on fasting during chemotherapy and time restricted eating
  • Q and A

Session 4

  • Understanding mainstream markers used for assessing hormonal factors and appropriate functional tests and nutrition modulation
  • Metabolic syndrome support: Evidence regarding supplements to support glycaemic control and promote weight loss in obese people affected by cancer and principles of safe practice regarding supplementation
  • Endocrine- modulating supplements. What are the mechanisms at play and what does the evidence tell us?  Clinical case study of a hormone-dependent cancer.
  • Case study exercise: Developing nutritional recommendations for long-term support through breast cancer treatment and survivorship stages.
  • Q and A

Integrative nutrition support through the cancer journey alongside novel therapies.

Session 1

  • The evolving treatment landscape with targeted therapies – medical treatment choices and patient selection
  • Cancers of the lungs: Use of tyrosine kinase inhibitors (TKIs). Case study of a patient with   lung cancer receiving EGFR-TKI
  • Cancer risk factors and the role of inflammation in cancer pathobiology
  • Understanding TKI  treatment side effects including skin changes and gastrointestinal distress
  • Integrative nutritional support during EGFR-TKI treatment to reduce side effects
  • Supplement safety during EGFR-TKI therapies – key considerations and drug nutrient interactions
  • Case study exercise using a lung cancer case study.
  • Q and A

Session 2

  • Cancer of the ovary: Use of targeted PARP inhibitors. Case study of a patient with  ovarian cancer receiving first-line chemotherapy and then olaparib.
  • Integrative nutritional support during treatment  to support tolerance and reduce side effects
  • Supplement safety and  the antioxidant paradox: Review of mechanisms and research concerning antioxidant supplementation
  • Implications for safe practice
  • Case study exercise using a peritoneal cancer case study.
  • Q and A

Session 3

  • Melanomas. Case study of a patient with advanced melanoma receiving combination checkpoint inhibitors
  • Mechanisms of action of checkpoint inhibitors
  • Evidence on the influence of the microbiome and diet on immunotherapy success
  • Integrative nutritional support during checkpoint inhibitor therapy
  • Q and A

Session 4

  • Supplement safety during immunotherapy: the dilemma of probiotics and key drug nutrient interactions
  • Health care professional roles and responsibilities in the context of cancer care and effective collaboration for patient safety: Key principles.
  • Reflective exercise on integrative nutrition in modern cancer care
  • Q and A
  • Explanation of case study assessment and timings


Who is leading the course?

Dr Carol Granger DProf BSc(Hons) MSc MRSB CBiol FBANT

Carol is a Registered Nutritional Therapist with 15 years’ experience of working with people affected by cancer. This area of clinical practice was the focus of her professional doctorate in health sciences from the University of Westminster.

Carol is a chartered biologist with a degree in biochemistry and a Master’s in microbiology, and training in herbal medicine. She has worked in various healthcare roles throughout her career before choosing to retrain in nutritional therapy; including microbiology research, clinical diagnostics, medical technology and human tissue banking. Carol is an independent contributor to research within the National Institute for Health Research (NIHR) collaboration on nutrition and cancer. She acts as a consultant to Penny Brohn UK, a leading charity providing the whole person approach to supporting people affected by cancer. Carol is also consultant nutritionist to a collaboration with leading oncologists who recognise the importance of nutrition for people with a cancer diagnosis.

Carol is a director of the British Society for Integrative Oncology (BSIO) and is Co-Chair and trustee of the Research Council for Complementary Medicine (RCCM). She teaches on several nutritional therapy courses at degree and Master’s level, and for 10 years was the Chair of NTEC, the accreditation body for training in nutritional therapy.

For more information please see:

ORCID page: https://orcid.org/0000-0003-4791-5593 | https://www.researchgate.net/profile/Carol_Granger/research | https://carolgranger.academia.edu/


How will I be taught?

ION’s CPD courses reflect best practice for online teaching and learning practice. This is an edited recording of a live course that ran over three days. It contains presentations interspersed with individual reflection exercises and recorded Q&A sessions.


How much does it cost and what’s included?

The course price is £267.00 

  • PDF of presentation and a reference document 
  • Approx. 15 hours edited recording
  • Viewing access for a least 90 days. You can access the course up to 10 times
  • BANT CPD 15 hours, NNA 15 hours, NTOI 15 hrs


What’s not included in the price?

This course is also certified by the Nutritional Therapy Education Commission (NTEC), the professional body that accredits professional training. 

If you additionally wish to gain NTEC certification for this course, you must also complete and pass a formal assessment of learning (approx. 8-12 hours of work) after the course to demonstrate not just participation in the course but also that you have internalised and reflected on the content.  Practitioners who see clients are able to choose from two case studies and those who do not see clients are able to prepare a concise article chosen from two topics. These will be marked by Dr Granger. 

Taking the assessment costs £100 and is non- refundable. There are two submission points in 2022 -Friday April 29th and Friday 30th September 2022.

Practitioners should check the requirements of their professional body when working with clients with cancer.  NTEC certification is not a formal qualification.

For further information, please contact [email protected]


Important information

About this On Demand Recording

  • Dr Carol Granger is not present on this recording and you will not be able to ask questions but you will be able to see the recorded Q and A sessions.
  • The course has been developed as a three day course- it is not possible to only purchase one day
  • This course was recorded in November 2021. All recordings are removed approximately one year after they are recorded so that we can ensure our courses contain up to date information.

Bookings

  • Please check you have read ION’s FAQs including our cancellation and refund policy before booking
  • Please ensure you use the same name and email to register, login and purchase tickets on our website and any partner platforms.
  • If applicable, where you are booking with a discount code, please check you have read ION’s discount terms and conditions: https://www.ion.ac.uk/promotions
  • Click the "BOOK" button at the top or bottom of this page- you will be taken to our webinar platform 'Big Marker' to purchase your ticket.
  • Ensure you are booking for the "series", which will cover the two days, rather than a single day

Registration links and materials

  • You will be automatically sent a link to the course when you register. Please do not share this with anyone. This is set up to only allow entry to the first user that clicks it. Further links cannot be generated.
  • Your booking confirmation email contains the password needed to access course materials (where applicable). Please type (rather than copying and pasting) this password when prompted and please ensure there are no spaces at the beginning or end.
  • To download the course materials, click the HANDOUTS button in the video player (situated between the VOLUME and QUESTIONS buttons). 
  • You are responsible for providing your correct email address across all ION and ION partner platforms.

CPD

  • Participation in an ION CPD course forms part of a practitioner's or individual's ongoing learning. It does not qualify a non-clinically trained practitioner or individual to work in a clinical setting. Individual’s boundaries of safe work, advice or practice are primarily determined by their formal qualifications and related personal insurance.
  • This on-demand recording is recognised by BANT for 15 hrs CPD  (applicable to BANT members only)
  • Non BANT registered practitioners may use this course for their CPD depending on the requirements and guidance of their professional body.

If you have a queries, please email [email protected]